drugset / Trial / NCT01216163
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will compare the analgesic efficacy of a single-dose of a novel ibuprofen formulation to placebo and acetaminophen in the treatment of post-surgical dental pain following "wisdom" tooth (third molar) removal.
Timeline
- Start
- 2010-10
- Primary completion
- 2011-01
- Completion
- 2011-01
Outcome
Met primary endpoint
registry Placebo vs Ibuprofen Sodium; p <0.001; Least-squares (LS) mean difference 17.68 (95% CI 13.08 to 22.27) NCT01216163 ↗
registry Placebo vs Ibuprofen Sodium; p <0.001; Hazard Ratio (HR) 11.84 (95% CI 5.13 to 27.36) NCT01216163 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 1000 mg | — |
| Subject | Ibuprofen | Small molecule | 512 mg | — |
Indications
No indication recorded.